Read more
2:44 PM · 5 February 2024

أهم تقارير الأسهم التي يجب مراقبتها هذا الأسبوع (05.02.2024)

موسم أرباح وول ستريت على قدم وساق. لقد شهد المستثمرون بالفعل تقارير من أكبر شركات التكنولوجيا الأمريكية، والتي كانت المحرك الرئيسي لارتفاع سوق الأسهم في عام 2023. ومع ذلك، هذا لا يعني أنه لا توجد أي شركات أخرى مثيرة للاهتمام للإبلاغ عنها. في تقويم أرباح هذا الأسبوع يمكن للمرء العثور على 4 أعضاء في مؤشر داو جونز - Amgen (AMGN.US)، كاتربيلر (CAT.US)، ماكدونالدز (MCD.US) ووالت ديزني (DIS.US)، اثنان منهم سيعلنان عن أرباحهما اليوم. ومن بين أبرز أحداث الأسبوع، يمكن للمرء أيضًا العثور على تقارير من شركات مثل Alibaba Group (BABA.US)، أو Arm Holdings (ARM.US)، أو Ford Motor (F.US)، أو PepsiCo (PEP.US). يمكن الاطلاع على الجدول الزمني لتقارير أرباح وول ستريت الأكثر إثارة للاهتمام والمقررة لهذا الأسبوع في الجدول أدناه.

من المقرر صدور تقارير أرباح وول ستريت لهذا الأسبوع.

المصدر: Bloomberg Finance LP, XTB Research.

5 May 2026, 1:12 PM

Market Wrap: European stock markets are up 🚀 Banks, defense, and tech in the spotlight 💡

4 May 2026, 9:39 PM

Daily summary: Conflict escalates again - indices down, oil up

4 May 2026, 9:02 PM

Palantir preview: Another record or another sell-off?

4 May 2026, 7:07 PM

Will GameStop buy eBay? The numbers suggest otherwise

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.